Forsight Vision 6 Overview
Forsight Vision 6 (FSV6) is developing an accommodating intraocular lens (AIOL) designed to enable precise vision across all distances after cataract surgery. The approach is differentiated, placing the lens over rather than within the capsular bag, thereby avoiding the stiffening that hinders accommodation. FSV6 was founded in the ForSight Labs ophthalmic incubator.
Cumulative Funding Raised Over Time ($)
Latest News
growth-positive
Forsight Vision6 drums up another $3m
ForSight Vision6, a company from ophthalmology incubator ForSight Labs, has raised $3.0 million in an equity round from a syndicate of nine unnamed investors. This follows a previous funding round of $1 million in 2015. ForSight Labs has a track record of successful spinouts, with Allergan acquiring ForSight Vision5 for $95 million. ForSight Vision6 is focused on developing the Helios ring, a drug-eluting ophthalmological implant designed to reduce intraocular pressure in glaucoma patients.
Investment
growth-positive
ForSight moves on to VISION6 with $6M equity funding round
ForSight Labs is seeking $6 million in funding for its VISION6 project. The company has already raised $1 million through equity sales. This funding round follows a recent $15 million Series C round for the VISION5 project, led by H.I.G. BioVentures.
Investment
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $4M |
| Last funding | $3M |
| Stage | Mature |
| Rounds | 3 |
| Investors | 0 |
Team Members
2
Employees: 11-50
Web & Social Links
Locations
Maskit Street 15, Herzliya, Israel
191 Jefferson Dr, Menlo Park, California, USA
Photos & Videos
No files yet
